| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 11.423 | 25.849 | 27.559 | 37.494 | 25.484 | 39.806 | 44.188 | - | - |
| Total Income - EUR | - | 11.423 | 25.849 | 27.559 | 37.494 | 25.485 | 39.806 | 45.811 | - | - |
| Total Expenses - EUR | - | 7.973 | 16.258 | 23.011 | 26.493 | 19.194 | 29.455 | 40.112 | - | - |
| Gross Profit/Loss - EUR | - | 3.449 | 9.591 | 4.548 | 11.002 | 6.291 | 10.351 | 5.698 | - | - |
| Net Profit/Loss - EUR | - | 3.107 | 8.815 | 3.721 | 9.877 | 5.526 | 9.288 | 4.351 | - | - |
| Employees | - | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Ortobrand Biomaterials Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 39 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Current Assets | - | 4.923 | 15.168 | 33.645 | 38.595 | 45.748 | 58.533 | 44.350 | - | - |
| Inventories | - | 0 | 2.108 | 5.265 | 5.749 | 6.288 | 11.076 | 18.519 | - | - |
| Receivables | - | 2.009 | 2.278 | 8.521 | 2.192 | 2.564 | 2.926 | 18.586 | - | - |
| Cash | - | 2.915 | 10.783 | 19.858 | 30.654 | 36.895 | 44.531 | 7.245 | - | - |
| Shareholders Funds | - | 3.151 | 11.913 | 15.416 | 24.994 | 30.046 | 38.668 | 4.392 | - | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | - | 1.811 | 3.255 | 18.229 | 13.601 | 15.701 | 19.865 | 39.958 | - | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Ortobrand Biomaterials Srl